Live symbol workspace

ABT market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $89.46

Trend Flat

Sentiment Neutral

{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support

$84.99

Resistance

$93.93

Volume & Momentum

Volume

Weak

0.8x avg

Momentum

0%

Weak

Technical Context

Current price

$89.46

RSI context

50

Market Sentiment

50

Neutral

Stock Metrics

Daily Vol

0%

VIX Est

20

Weekly

0%

Asset Intelligence Dossier

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

33%

▲ 3.3 pts vs previous week

Avg confidence across 6 calls in the last 7 days

What sources say

Neutral 1 article

Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth

Insider Trading

Refreshing insider trades from FinViz…

Technical Observations

Refreshing technical observations from FinViz...

ABT News Intelligence (4 articles)

AI-curated news influencing ABT price, sentiment, and trend

Explore All ABT News with AI Analysis

Economy

1 hour, 54 minutes ago

Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth

Jensen Investment Management, an asset management company based in the US, released its second-quarter 2026 investor letter for the “Jensen …

Impact on ABT: Neutral market sentiment indicated

Analysis of stock market developments showing neutral sentiment. Medium (50%)

View full analysis →

Yahoo Finance 50% confidence

Economy

1 month, 2 weeks ago

Abbott declares 410th consecutive quarterly dividend

The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.

Impact on ABT: The declaration of the 410th consecutive quarterly dividend is expected to have …

Abbott declares its 410th consecutive quarterly dividend of 63 cents per share, reinforcing its commitment … High (70%)

View full analysis →

Yahoo Finance 70% confidence

Economy

2 months ago

Waiting on Integration Result, Market Stays Moderated on Abbott Laboratories (ABT)

Alpha Wealth Funds, LLC, an investment management company, released its Q1 2025 letter for the “Insiders Fund”. A copy of …

Impact on ABT: May pressure downward momentum

Financial market analysis indicating bearish sentiment based on current trends. Medium (60%)

View full analysis →

Yahoo Finance 60% confidence

Economy

2 months, 4 weeks ago

Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the …

Impact on ABT: The exit of ABT by Polen Capital may lead to a short-term …

Polen Capital's Q1 2026 investor letter revealed the exit of Abbott Laboratories (ABT) from its … Medium (50%)

View full analysis →

Yahoo Finance 50% confidence